Contract research and testing laboratories can now access AMSBIO’s high-efficiency DUB enzyme assay kits, engineered for streamlined analysis in the ubiquitin-proteasome pathway. These kits are pre-optimized for high-throughput testing in standard 96-well plate format, ideal for screening inhibitors or quantifying DUB activity.
The assays use fluorescent ubiquitin substrates to deliver sensitive detection without the need for substrate preparation. With specific kits available for DUBs such as BAP1, USP7, and UCHL1, testing services can expand their capabilities into areas of drug discovery and disease pathway validation.
Flexible for use with both purified proteins and cell-based samples, these kits support precision workflows in oncology, neurodegenerative disease studies, and immune response profiling.
Advantages for Contract Testing Labs:
- Turnkey format reduces sample processing time
- Enables scalable, high-throughput analysis
- Supports inhibitor screening and validation
- Compatible with diverse biological samples
- Adds value for clients in pharma and biotech sectors
- Facilitates studies in disease-linked cellular pathways
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. The original press release was provided by AMSBIO.
